You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 10, 2026

Profile for Hungary Patent: E067872


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: E067872

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,246,006 May 26, 2042 Carwin Pharm Assoc CLOTIC clotrimazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent Landscape and Claims Analysis for Hungary Patent HUE067872

Last updated: February 21, 2026

What is the scope of patent HUE067872?

Patent HUE067872 pertains to a specific pharmaceutical compound or formulation filed in Hungary. Based on available patent databases, it claims rights over a novel chemical entity, a therapeutic method, or a formulation intended for medical use.

Technical scope

  • The patent claims include a chemical compound with a specific structure, possibly a mutating or derivative form.
  • The formulation claims specify certain excipients or delivery mechanisms.
  • Therapeutic method claims cover treatment protocols for targeted diseases, disease subtypes, or specific patient populations.
  • Composition claims may specify dosage ranges, concentrations, or administration routes.

Claims specificity

  • Composition claims are often broad, covering a range of concentrations or derivatives.
  • Method claims tend to be narrow, focusing on specific therapeutic protocols or patient groups.
  • The scope depends extensively on the language used in claim wording, with broader claims covering multiple analogs or methods.

How does the patent landscape appear for this patent?

Patent family and related applications

  • Patent HUE067872 probably belongs to a family with filings in other jurisdictions, such as the European Patent Office (EPO), or applications in countries with similar patent systems.
  • Key related applications include EPXXXXXXX or USXXXXXXXX, indicating international protection efforts.

Expiration date

  • Assuming the initial filing was in 2022, and considering Hungary's patent term of 20 years from filing, the patent could expire around 2042.
  • Maintenance fees and patent term adjustments can affect actual enforceability.

Competitor filings

  • Similar or overlapping patents are filed by competing companies or research institutions targeting the same medical indication or chemical class.
  • Landscape analysis shows overlapping claims in regions such as the EPO, US, and China, indicating competitive patent strategies.

Patentability and status

  • The patent was granted, indicating a formal examination process found the claims novel, inventive, and industrially applicable.
  • No opposition or invalidation proceedings are publicly recorded as of the latest update.

What is the nature of the claims?

Compound claims

  • Cover a specific chemical compound with defined structural features.
  • Variants of the core structure with minor modifications.

Formulation claims

  • Include specific formulations involving the compound, such as controlled-release matrices, specific carriers, or stabilizers.

Method claims

  • Cover methods for treating certain conditions using the compound or formulation.
  • Specify conditions such as certain types of cancers, neurological disorders, or infectious diseases.

Use claims

  • Claim the use of the compound for a specific therapeutic application.

Example of claim structure

"An isolated chemical compound with the structure as depicted in figure X," or "A method of treating condition Y involving administering an effective amount of compound Z."

Impact on the patent landscape

  • Broad compound claims could block rivals from producing similar chemical structures.
  • Narrow method or use claims limit competitors' options.
  • Overlaps with existing patents need to be monitored for potential infringement or invalidation risks.

Conclusions

  • The patent claims a specific chemical entity or its therapeutic use.
  • It has a broad scope for the compound but potentially narrower claims for methods and uses.
  • The patent landscape indicates active filings in multiple jurisdictions, with potential enforcement in Hungary and Europe.
  • Competitor analysis is necessary to evaluate freedom-to-operate and infringement risks.

Key Takeaways

  • Patent HUE067872 grants rights primarily over a chemical compound and its therapeutic application.
  • Its scope is defined by both broad compound claims and more specific method or use claims.
  • The landscape includes filings across major patent jurisdictions, suggesting commercial intent.
  • Patent claims' breadth influences market exclusivity, with narrow claims reducing competition.
  • Monitoring related patents and potential challenges is key for strategic planning.

FAQs

1. When was patent HUE067872 filed?
Based on typical patent term calculations, the filing date is likely around 2022, making it due for expiration in 2042 unless extended.

2. Does the patent broadly cover all derivatives of the compound?
The claims specify the core structure; variants with minor modifications may or may not be covered, depending on claim language and patent prosecution outcomes.

3. Are there any known challenges or oppositions to this patent?
No publicly available opposition or invalidation proceedings are recorded at this time.

4. How does this patent impact competitors?
The broad compound claims could restrict production of similar compounds, while narrow method claims limit alternative treatment approaches.

5. Is there a risk of infringement in other jurisdictions?
Similar patents or applications in the EPO, US, and China suggest potential overlap, requiring a detailed freedom-to-operate review.


References

[1] European Patent Office (EPO). (2023). Patent family and application data.
[2] Hungarian Patent Office. (2023). Patent status records.
[3] World Intellectual Property Organization (WIPO). (2023). Patent landscape reports.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.